Karel Pavelká
Institute and Cliníc of Rheumatology
Charles University
Na Slupi 4
128 50 Prague 2
Czech Republic
Name/email consistency: high
- Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs. Pavelka, K., Kavanaugh, A.F., Rubbert-Roth, A., Ferraccioli, G. Rheumatology. (Oxford) (2012)
- Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA. Pavelka, K., Forejtová, S., Stolfa, J., Chroust, K., Buresová, L., Mann, H., Vencovský, J. Clin. Exp. Rheumatol. (2009)
- Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy. Pavelka, K., Jarosová, K., Suchý, D., Senolt, L., Chroust, K., Dusek, L., Vencovský, J. Ann. Rheum. Dis. (2009)
- The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. Pavelka, K., Trc, T., Karpas, K., Vítek, P., Sedlácková, M., Vlasáková, V., Böhmová, J., Rovenský, J. Arthritis Rheum. (2007)
- Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Pavelka, K., Forejtová, S., Olejárová, M., Gatterová, J., Senolt, L., Spacek, P., Braun, M., Hulejová, M., Stovícková, J., Pavelková, A. Osteoarthr. Cartil. (2004)
- Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Pavelká, K., Gatterová, J., Olejarová, M., Machacek, S., Giacovelli, G., Rovati, L.C. Arch. Intern. Med. (2002)
- A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee. Pavelká, K., Gatterová, J., Gollerova, V., Urbanová, Z., Sedlácková, M., Altman, R.D. Osteoarthr. Cartil. (2000)
